GO Term |
---|
endopeptidase activity |
exopeptidase activity |
tripeptidyl-peptidase activity |
actin binding |
carboxypeptidase activity |
metalloendopeptidase activity |
metallopeptidase activity |
calmodulin binding |
peptidyl-dipeptidase activity |
zinc ion binding |
Position | Description |
---|---|
523 | Not glycosylated |
1225 | Not glycosylated |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
368 | N-linked (GlcNAc...) asparagine |
|
||
445 | N-linked (GlcNAc...) asparagine | |||
509 | N-linked (GlcNAc...) asparagine | |||
523 |
|
|||
617 | N-linked (GlcNAc...) asparagine |
|
||
625 |
|
|
||
677 | N-linked (GlcNAc...) asparagine | |||
695 | N-linked (GlcNAc...) (complex) asparagine |
|
||
714 | N-linked (GlcNAc...) (complex) asparagine | |||
760 | N-linked (GlcNAc...) asparagine; partial |
|
Pathway Name | Organism |
---|---|
Metabolism of Angiotensinogen to Angiotensins | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0110197 | Charcot-Marie-Tooth disease dominant intermediate B | |
DOID:0110198 | Charcot-Marie-Tooth disease recessive intermediate C | |
DOID:0110199 | Charcot-Marie-Tooth disease dominant intermediate C | |
DOID:0110200 | Charcot-Marie-Tooth disease dominant intermediate D | |
DOID:0110202 | Charcot-Marie-Tooth disease dominant intermediate A | |
DOID:0110203 | Charcot-Marie-Tooth disease recessive intermediate D | |
DOID:0110204 | Charcot-Marie-Tooth disease recessive intermediate B | |
DOID:0110205 | Charcot-Marie-Tooth disease dominant intermediate E | |
DOID:419 | scleroderma | |
DOID:0110206 | Charcot-Marie-Tooth disease dominant intermediate F |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024